Brim Biotechnology Inc.
Clinical trials sponsored by Brim Biotechnology Inc., explained in plain language.
-
New eye drops aim to soothe dry eye in just two weeks
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely relieve dry eye symptoms better than a placebo. About 220 adults with dry eye for at least 6 months used the drops or a placebo for 14 days. Researchers measured changes in eye surface damage and dryness scores to see if the t…
Phase: PHASE2, PHASE3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops are safe and effective for treating dry eye. 157 adults with dry eye for at least 6 months received either the drug or a placebo. Researchers measured changes in eye surface staining and discomfort scores to see if the drops improve sign…
Phase: PHASE2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC